<DOC>
	<DOC>NCT00338130</DOC>
	<brief_summary>The primary purpose of this study is to compare the efficacy of AZD6244 (ARRY-142886) with temozolomide in patients with advanced melanoma</brief_summary>
	<brief_title>Randomised Study to Compare the Efficacy of AZD6244 vs TMZ</brief_title>
	<detailed_description />
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Temozolomide</mesh_term>
	<mesh_term>Dacarbazine</mesh_term>
	<criteria>Diagnosed with late stage malignant melanoma Aged 18 or over Female patients must be postmenopausal or with negative urine pregnancy test if premenopausal Any previous radiotherapy or chemotherapy (palliative radiotherapy is acceptable) Participation in any other trial with an investigational product within the previous 30 days</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Melanoma</keyword>
	<keyword>Phase II</keyword>
	<keyword>AZD6244</keyword>
	<keyword>temozolomide</keyword>
</DOC>